Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LZM012
BIOLOGICAL
2 trials
Sponsors
Livzon Pharmaceutical Group Inc.
Conditions
Psoriasis
Phase 3
A Study to Evaluate the Efficacy and Safety of LZM012
NCT06110676
Livzon Pharmaceutical Group Inc.
Psoriasis
Start: 2023-08-21
End: 2025-06-30
Target: 918
Updated: 2023-11-01
A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )
Completed
NCT07746479
Livzon Pharmaceutical Group Inc.
Psoriasis
Start: 2025-06-23
End: 2026-01-26
Updated: 2026-08-05